輸卵管切除用于預(yù)防卵巢癌課件_第1頁
輸卵管切除用于預(yù)防卵巢癌課件_第2頁
輸卵管切除用于預(yù)防卵巢癌課件_第3頁
輸卵管切除用于預(yù)防卵巢癌課件_第4頁
輸卵管切除用于預(yù)防卵巢癌課件_第5頁
已閱讀5頁,還剩18頁未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡介

Contents1Introduction2Strategy3ChallengesForward4Conclusion1輸卵管切除用于預(yù)防卵巢癌美國婦產(chǎn)科醫(yī)師協(xié)會(huì)委員會(huì)在提出“切除輸卵管可能預(yù)防卵巢癌”這一觀點(diǎn)。ObstetGynecol.2015;125:279-281.FulltextCommitteeonGynecologicPractice

Thisdocumentreflectsemergingclinicalandscientificadvancesasofthedateissuedandissubjecttochange.Theinformationshouldnotbeconstruedasdictatinganexclusivecourseoftreatmentorproceduretobefollowed.2Counselingwomenwhoareundergoingroutinepelvicsurgeryabouttherisksandbenefitsofsalpingectomyshouldincludeaninformedconsentdiscussionabouttheroleofoophorectomyandbilateralsalpingo-oophorectomy.“

Theopinionspecificallyaddresseswomenat"populationrisk"forovariancancer,meaningwomenwhodonothaveanelevatedgeneticriskforovariancancerbutwhoarehavingroutinepelvicsurgeryforbenigndisease.3對(duì)于卵巢癌“大”進(jìn)行常規(guī)盆腔手術(shù)的女性,對(duì)于輸卵管切除風(fēng)險(xiǎn)和好處的咨詢應(yīng)該包括卵巢切除術(shù)和雙側(cè)輸卵管切除術(shù)的一個(gè)知情同意書。4Salpingectomyatthetimeofhysterectomyorasameansoftubalsterilizationappearstobesafe,withoutanincreaseinparedwithhysterectomyaloneortuballigation,"thecommitteewrites.婦產(chǎn)科醫(yī)師協(xié)會(huì)認(rèn)為,與單純子宮切除術(shù)或輸卵管結(jié)扎術(shù)相比,在子宮切除時(shí)行輸卵管切除術(shù)或者輸卵管絕育術(shù)似乎是安全的,不會(huì)增加并發(fā)癥。5nwomenconsideringlaparoscopicsterilization,physicianscandiscussthefactthatbilateralsalpingectomyprovideseffectivecontraception,whilepointingoutthatthisprocedureeliminatestheoptionoftubalreversal.對(duì)于考慮腹腔鏡絕育手術(shù)的婦女,醫(yī)生應(yīng)知會(huì)患者雙側(cè)輸卵管切除術(shù)可提供有效的避孕方法,同時(shí)指出這一手術(shù)后不可再行輸卵管復(fù)通術(shù)。6

婦科癌癥中,卵巢癌死亡率最高;在現(xiàn)在女性癌癥死亡率排名中已上升到第五名。卵巢癌存活率在最近50年中并沒有明顯改善7Morerandomizedcontrolledtrialsareneededtosupporttheuseofsalpingectomyinreducingovariancancer有關(guān)使用輸卵管切除術(shù)預(yù)防卵巢癌的做法,還需要更多的隨機(jī)對(duì)照試驗(yàn)進(jìn)行驗(yàn)證。8Thecommitteeurgessurgeonstocontinuetouseminimallyinvasivetechniques.Fornow,thepossiblebenefitofsalpingectomyshouldnotswaydecisionsaboutwhichtechniquetouseforhysterectomyandsterilization.Forexample,thecommitteeadvisessurgeonsnottoswitchfromvaginaltolaparoscopichysterectomysimplytodoasalpingectomy.委員會(huì)敦促醫(yī)生繼續(xù)使用微創(chuàng)手術(shù)。目前,輸卵管切除術(shù)可能的獲益還不能影響子宮切除術(shù)和結(jié)扎手術(shù)的技術(shù)決策。例如,例如委員會(huì)建議外科醫(yī)生不要僅僅為了做一個(gè)輸卵管切除術(shù),而從陰道子宮切除術(shù)轉(zhuǎn)變?yōu)楦骨荤R子宮切除術(shù)。9Thelattertechniquescancauseearlymenopauseandincreasedriskforcardiovasculardisease,osteoporosis,andcognitiveimpairmentandwerealsolinkedtoincreasedriskforall-causeandcancerspecificmortalityintheNurses'HealthStudy.后者會(huì)導(dǎo)致更年期提前,心血管疾病風(fēng)險(xiǎn)增加,骨質(zhì)疏松和認(rèn)知障礙,并且在護(hù)士健康研究中發(fā)現(xiàn),并與所有原因和癌癥死亡專率風(fēng)險(xiǎn)增加有關(guān)。10Onthebasisofcurrentviewsaboutovariancarcinogenesis,thecommitteecontinues,salpingectomywhileleavingtheovariesintactmaybebetterforcancerpreventionthanoophorectomyandbilateralsalpingo-oophorectomy.基于目前有關(guān)卵巢癌變的觀點(diǎn),委員會(huì)認(rèn)為單純切除輸卵管,保留完整卵巢可能比卵巢切除術(shù)和雙側(cè)輸卵管、卵巢切除術(shù)預(yù)防癌癥的效果更好。11hemostcompellingtheoryofepithelialovariancarcinogenesissuggeststhatserous,endometrioid,andclearcellcarcinomasarederivedfromthefallopiantubeandtheendometriumandnotdirectlyfromtheovary(5–9).Thisisincontrasttothetraditionalviewofovariancarcinogenesisinwhichovariansurfaceepithelium(mesothelium)undergoesmetaplasticchangesleadingtothedifferenthistologictypesofepithelialovariancancer.Inwomenwithageneticpredispositionforovariancancer,lesionshavebeenfoundinthefallopiantubesthatcloselyresembleovarianhigh-gradeserouscarcinomasorseroustubalintraepithelialcarcinomas.Theselesionsarethoughttobetheprimarysourceofovariancarcinomathatsecondarilyinvolvestheovary.Geneticsstudiesshowthatthesetuballesionsexpressacommon

TP53

mutation,asdohigh-gradeserous,high-gradeendometrioid,andundifferentiatedcarcinomas.Inaddition,geneexpressionofhigh-gradeserouscarcinomasismorecloselyrelatedtothefallopiantubemorphologythantheovariansurfaceepithelium.High-gradeserouscarcinomasexpressamüllerianmarker(PAX8)butnotamesothelialmarker(calretinin).12委員會(huì)認(rèn)為,大約75%的卵巢癌和90%的卵巢癌導(dǎo)致的死亡是由上皮性卵巢癌造成的。目前沒有可靠的卵巢癌篩查方案。傳統(tǒng)觀點(diǎn)認(rèn)為上皮性卵巢癌起因于卵巢的一小部分,最新研究表明,上皮性卵巢癌源自輸卵管和子宮內(nèi)膜的一部分。研究還指出輸卵管結(jié)扎對(duì)子宮內(nèi)膜透明細(xì)胞癌起預(yù)防作用。13

總結(jié):基于女性中卵巢癌的人口風(fēng)險(xiǎn)比例,外科醫(yī)生應(yīng)該對(duì)輸卵管切除術(shù)的潛在好處進(jìn)行討論。在全子宮切除時(shí),對(duì)于有卵巢癌風(fēng)險(xiǎn),希望保留卵巢的患者,討論切除輸卵管的利弊。3.醫(yī)生應(yīng)該告知考慮腹腔鏡絕育手術(shù)的女性,雙側(cè)輸卵管切術(shù)可以提供有效避孕,并應(yīng)該指出這個(gè)手術(shù)還可以避免輸卵管扭轉(zhuǎn)這個(gè)疾病。4.對(duì)于一些患者而言,預(yù)防性輸卵管切除術(shù)可能預(yù)防卵巢癌。

14

15

1617Clicktoeditheadline

Competitors

YoumaywanttoallocateoneslidepercompetitorStrengths

YourstrengthsrelativetocompetitorsWeaknesses

Yourweaknessesrelativetocompetitors18Clicktoeditheadline2004200320022001step1step1step1step1Clicktoedityourtitle19ClicktoeditheadlineConclusion1Conclusion2Clicktoedityoursubject1Clicktoedityoursubject1Clicktoedityoursubject1Clicktoedityoursubject2Clicktoedityoursubject2Clicktoedityoursubject220ClicktoeditheadlineConclusion1ClicktoedityourtextClicktoedityourtextClicktoedityourtext21Clicktoeditheadline

Example01

Example02

Example03

Example04subject22ClicktoeditheadlineClicktoedittextCl

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論